Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Creotech Instruments's Other Operating Expense for the
three
months ended in Mar. 2026 was zł26.6 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł129.7 Mil.
Creotech Instruments's quarterly Other Operating Expense
increased
from Sep. 2025 (zł24.1 Mil) to Dec. 2025 (zł28.7 Mil) but then
declined
from Dec. 2025 (zł28.7 Mil) to Mar. 2026 (zł26.6 Mil).
Creotech Instruments's annual Other Operating Expense
declined
from Dec. 2023 (zł36.1 Mil) to Dec. 2024 (zł34.3 Mil) but then
increased
from Dec. 2024 (zł34.3 Mil) to Dec. 2025 (zł111.9 Mil).
Creotech Instruments Other Operating Expense Related Terms
Creotech Instruments Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Creotech Instruments's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creotech Instruments Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł129.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of zł129.7 Mil mean?
Creotech Instruments (WAR:CRI) has a Other Operating Expense of zł129.7 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Creotech Instruments and its competitors.
Is Creotech Instruments' Other Operating Expense too high?
Creotech Instruments' current Other Operating Expense is zł129.7 Mil. Overall, Creotech Instruments has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' Other Operating Expense compare to SPCX and GE?
Creotech Instruments' Other Operating Expense of zł129.7 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for an Aerospace & Defense company?
A good Other Operating Expense depends on the Aerospace & Defense industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Creotech Instruments and its competitors. Creotech Instruments's current Other Operating Expense is zł129.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Modestly Undervalued. The stock's GF Value™ is zł963.16, compared to a current price of zł701.00 — trading 27.2% below its estimated fair value. The current Other Operating Expense is zł129.7 Mil. Creotech Instruments' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current Other Operating Expense is zł129.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creotech Instruments (WAR:CRI) Overvalued in 2026?
Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued.
The current stock price of zł701.00 is trading 27.2% below its estimated GF Value™ of zł963.16.
GuruFocus considers Creotech Instruments to be Modestly Undervalued.
Key valuation signals for WAR:CRI:
Other Operating Expense: zł129.7 Mil
GF Value™: zł963.16 vs. price of zł701.00 (27.2% below fair value)
No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
75GF Score
Get the complete analysis for WAR:CRI
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CRI has been successfully added to your 
